Abbvie Inc. vs Cencora, Inc.
ABBV vs COR — side-by-side comparison from reported financials. ABBV leads 4, COR leads 8 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Cencora, Inc.
COR · Healthcare
$323.85+0.78%Solid
| Metric | ABBV | COR |
|---|---|---|
| Price | $276.43 | $323.85 |
| Market cap | $488B | $61.8B |
| Revenue (TTM) | $64.4B | $333B |
| Revenue growth | +1.8% | +10.4% |
| Net margin | 9.8% | 0.8% |
| Free cash flow | $18.2B | $4.06B |
| Net cash (debt) | ($56.2B) | ($3.30B) |
| 1-year price return | +19.8% | +3.1% |
| P/E | 77.4 | 23.5 |
| P/E vs own history (cheap-side %) | 23% | 83% |
| Dividend yield | 2.45% | 0.76% |
| Return on equity | 96% | 106% |
| Altman Z-score | 2.33 | 3.66 |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 51,000 |
Full résumé-style profiles: ABBV CV · COR CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.